Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1

BACKGROUND: Interferon-free regimens to treat hepatitis C virus (HCV) genotype 1 are effective but costly. At this time, payers in the United States use strategies to control costs including (1) limiting treatment to those with advanced disease and (2) negotiating price discounts in exchange for exc...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Open Forum Infect Dis
Hoofdauteurs: Linas, Benjamin P., Morgan, Jake R., Pho, Mai T., Leff, Jared A., Schackman, Bruce R., Horsburgh, C. Robert, Assoumou, Sabrina A., Salomon, Joshua A., Weinstein, Milton C., Freedberg, Kenneth A., Kim, Arthur Y.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2016
Onderwerpen:
Major Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5414108/
https://ncbi.nlm.nih.gov/pubmed/28480259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofw266
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items